Medication-info.com Search Menu

Collavera (Xylocaine, Lidoderm, Lidocan) Package Insert

Status:
Prescription (Rx) Facts
Strength:
20 mg/g
Brand names:
Drug class:
Active ingredient:
Similar drugs:

Source: FDA drug labeling via NLM DailyMed · About this document

Prescribing information (package insert) - Collavera

DESCRIPTION

Collavera™ contains Lidocaine Hydrochloride 20 mg/g (2%) in a topical gel base.

INDICATIONS AND USAGE

Collavera™ is indicated for topical analgesia as directed by a healthcare provider.

WARNINGS

For external use only. Not for ophthalmic use.

Avoid contact with eyes.

Excessive application may result in systemic absorption. Use only as directed.

Keep out of reach of children.

OVERDOSAGE

Excessive topical application may increase systemic absorption of lidocaine and may result in central nervous system and cardiovascular effects. In the event of overdose, discontinue use and seek medical attention.

DOSAGE AND ADMINISTRATION

For topical use only.

Apply a thin layer to the affected area 3 to 4 times daily or as directed by a healthcare provider.

Avoid contact with eyes and mucous membranes.

HOW SUPPLIED

Collavera™ (Lidocaine Hydrochloride 20 mg/g) is supplied as a clear topical gel in a 1 oz (28.33 g) tube.

NDC 85477-305-07

About this document

Source: FDA drug labeling via NLM DailyMed · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Collavera

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Amide Local Anesthetic, Antiarrhythmic
Active ingredient Lidocaine 20 mg/g
Dosage form Gel
Route Topical
Marketing status listed in the FDA NDC Directory
Company (applicant) Oncora Pharma, LLC
FDA approval UNAPPROVED DRUG OTHERUnapproved drug
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
20 mg/g – 28.33 g in 1 bottle, plastic NDC 85477-305-07

Source: FDA drug labeling via NLM DailyMed, data as of November 3, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.